Heart failure (HF) is considered one of a leading cause of cardiovascular morbidity and
mortality worldwide. The association between HF and venous thromboembolism (VTE) has …

Thromboprophylaxis of hospitalized patients at risk of venous thromboembolism (VTE)
presents challenges owing to patient heterogeneity and lack of adoption of evidence-based …

In medical inpatients, the IMPROVE risk score had moderate predictive power for 14-d in-hospital
bleeding Page 1 In medical inpatients, the IMPROVE risk score had moderate predictive …

Current hospital venous thromboembolism (VTE) prophylaxis for medical patients is
characterized by both underuse and overuse. The American Society of Hematology (ASH) …

Background Inpatient and extended postdischarge thromboprophylaxis of COVID-19
patients remains suboptimal despite antithrombotic guidelines. Objectives To determine …

Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism,
is a life‐threatening, costly, and common preventable complication associated with …

Introduction: Hospital-acquired venous thromboembolisms (HA-VTEs) carry a significant
health burden on patients and a financial burden on hospitals due to reimbursement …

Venous thromboembolism (VTE) is a frequent complication of acute hospital care, and this
extends to in-patient rehabilitation. The timely use of appropriate thromboprophylaxis in …

The annual incidence of symptomatic deep venous thrombosis (DVT) and venous
thromboembolic (VTE)(DVT plus pulmonary embolism) in the adult population is estimated …

Hospital-associated venous thromboembolism (VTE) represents a significant and
preventable cause of morbidity and mortality, with nearly half of all VTE deaths in the United …